Marksans Pharma Ltd
Anjani Kumar has a diverse work history in the pharmaceutical industry, starting as a Marketing Professional at Themis Pharmaceutical in 1983. Anjani then worked at Lupin as a Production Chemist before joining Cipla in 1987. At Cipla, they held various roles, ultimately becoming the Head of Pharma Operations overseeing significant growth. Anjani later joined Wockhardt Ltd. as President of Global Operations. Anjani also founded their own company, Drogen Pharma, where they served as Director and CEO. Currently, they are the Chief Operating Officer of Global Operations at Marksans Pharma Ltd. Anjani also worked as a Senior consultant and advisor at The Quantic Group, Pharmaceutical Consultants.
Anjani Kumar completed a Bachelor's degree in Pharmaceutical Sciences from BIT Mesra Student-Industry Relations Cell from 1979 to 1983.
This person is not in any offices
Marksans Pharma Ltd
Marksans Pharma Limited is a pharmaceutical holding company. The Company is engaged in the research, manufacturing and marketing of generic pharmaceutical formulations. The Company's product portfolio addresses various therapeutic segments, including Pain management, Cough and cold, Anti-diabetic, Cardiovascular system, Central nervous system, Antibiotic, Gastrointestinal, Anti-allergic and Miscellaneous. The Company undertakes research and development initiatives, and offers customer relationship management (CRM) services to global pharmaceutical companies. The Company has a manufacturing facility for the manufacture of oral solid tablets and soft gelatin capsules in Goa; a liquids/ointments/sachets manufacturing facility in Southport, the United Kingdom, and a solid oral dosages manufacturing facility in New York, the United States. It supplies products to approximately 20 countries. Its subsidiaries include Nova Pharmaceuticals Australasia Pty Ltd. and Marksans Pharma (UK) Limited.